Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study

INTRODUCTION: In the stressful context of the coronavirus disease 2019 (COVID-19) pandemic, some reports have raised concerns regarding psychiatric disorders with the use of hydroxychloroquine. In this study, we reviewed all psychiatric adverse effects with hydroxychloroquine in COVID-19 patients, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Philippe, Revet, Alexis, Yrondi, Antoine, Rousseau, Vanessa, Degboe, Yannick, Montastruc, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571787/
https://www.ncbi.nlm.nih.gov/pubmed/33078372
http://dx.doi.org/10.1007/s40264-020-01013-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571787/
https://www.ncbi.nlm.nih.gov/pubmed/33078372
http://dx.doi.org/10.1007/s40264-020-01013-3

Ejemplares similares